ADAM33 expression in asthmatic airways and human embryonic lungs.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 15709049)

Published in Am J Respir Crit Care Med on February 11, 2005

Authors

Hans Michael Haitchi1, Robert M Powell, Timothy J Shaw, Peter H Howarth, Susan J Wilson, David I Wilson, Stephen T Holgate, Donna E Davies

Author Affiliations

1: Roger Brooke Laboratories, Division of Infection, Inflammation, and Repair, and Human Genetics Division, School of Medicine, University of Southampton, Southampton General Hospital, United Kingdom. h.m.haitchi@soton.ac.uk

Articles citing this

The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc (2009) 1.52

Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung. Virchows Arch (2009) 1.24

A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma. Am J Respir Crit Care Med (2009) 1.12

Role of ADAM and ADAMTS metalloproteinases in airway diseases. Respir Res (2009) 0.95

ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma. BMC Cancer (2009) 0.93

Differential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas. PLoS One (2007) 0.91

Soluble IgE receptors--elements of the IgE network. Immunol Lett (2011) 0.89

ADAM8: a new therapeutic target for asthma. Expert Opin Ther Targets (2009) 0.86

A possible association of EMID2 polymorphisms with aspirin hypersensitivity in asthma. Immunogenetics (2010) 0.85

The relationship between infant lung function and the risk of wheeze in the preschool years. Pediatr Pulmonol (2010) 0.85

DNA sequence variations of metalloproteinases: their role in asthma and COPD. Postgrad Med J (2007) 0.85

Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls. Indian J Med Res (2013) 0.82

Regulation of a disintegrin and metalloprotease-33 expression by transforming growth factor-β. Am J Respir Cell Mol Biol (2012) 0.82

Biophysical basis for airway hyperresponsiveness. Can J Physiol Pharmacol (2007) 0.81

An ADAM33 polymorphism associates with progression of preschool wheeze into childhood asthma: a prospective case-control study with replication in a birth cohort study. PLoS One (2015) 0.81

ADAM33 gene polymorphisms and mortality. A prospective cohort study. PLoS One (2013) 0.79

Mechanistic role of a disease-associated genetic variant within the ADAM33 asthma susceptibility gene. BMC Med Genet (2007) 0.78

Unravelling the role of ADAM 33 in asthma. Indian J Med Res (2013) 0.77

Down regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast Cancer. Sci Rep (2017) 0.75

Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life. JCI Insight (2016) 0.75

Association of ADAM33 gene polymorphisms with allergic asthma. Iran J Basic Med Sci (2014) 0.75

Articles by these authors

Air pollution and health. Lancet (2002) 9.57

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature (2002) 8.28

Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52

Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med (2011) 6.05

Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med (2005) 6.05

Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90

Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med (2007) 3.96

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12

Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet (2002) 3.11

Pathogenesis of asthma. Clin Exp Allergy (2008) 2.93

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med (2004) 2.81

The airway epithelium: structural and functional properties in health and disease. Respirology (2003) 2.73

Defective epithelial barrier function in asthma. J Allergy Clin Immunol (2011) 2.73

The mouse trap: It still yields few answers in asthma. Am J Respir Crit Care Med (2006) 2.68

A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56

Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet (2002) 2.50

Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 2.44

Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest (2005) 2.41

Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small (2009) 2.40

The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol (2006) 2.35

Airway remodeling in asthma: new insights. J Allergy Clin Immunol (2003) 2.32

Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometry. Lab Chip (2009) 2.28

Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol (2005) 2.27

Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome. Hum Mutat (2007) 2.20

The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc Am Thorac Soc (2009) 2.18

Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes (2005) 2.11

The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02

Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet (2003) 1.96

Free-drifting icebergs: hot spots of chemical and biological enrichment in the Weddell Sea. Science (2007) 1.94

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90

Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med (2004) 1.88

Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85

Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation. Am J Respir Crit Care Med (2011) 1.84

Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol (2002) 1.73

Proinflammatory doses of diesel exhaust in healthy subjects fail to elicit equivalent or augmented airway inflammation in subjects with asthma. Thorax (2010) 1.71

Factors associated with mortality after an asthma admission: a national United Kingdom database analysis. Respir Med (2007) 1.71

Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc (2004) 1.68

Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis (2002) 1.59

Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis (2008) 1.59

Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol (2005) 1.53

Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol (2002) 1.51

Prosurvival activity for airway neutrophils in severe asthma. Thorax (2010) 1.51

Tumor necrosis factor alpha (TNF-α) autoregulates its expression and induces adhesion molecule expression in asthma. Clin Immunol (2011) 1.45

Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. J Allergy Clin Immunol (2006) 1.44

The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts. Am J Respir Cell Mol Biol (2004) 1.42

Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med (2005) 1.40

Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches. J Allergy Clin Immunol (2009) 1.37

Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. Am J Respir Cell Mol Biol (2002) 1.36

Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med (2009) 1.35

Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol (2009) 1.35

Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am J Respir Cell Mol Biol (2003) 1.35

IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol (2007) 1.34

A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med (2002) 1.33

Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today (2011) 1.32

Genetics of allergic disease. J Allergy Clin Immunol (2010) 1.31

Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study. BMJ (2003) 1.29

Allergic diseases and asthma: a major global health concern. Curr Opin Allergy Clin Immunol (2012) 1.26

Characterization and multipotentiality of human fetal femur-derived cells: implications for skeletal tissue regeneration. Stem Cells (2005) 1.23

A new look at the pathogenesis of asthma. Clin Sci (Lond) (2009) 1.22

Analysis of novel disease-related genes in bronchial asthma. Cytokine (2002) 1.22

The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J Allergy Clin Immunol (2008) 1.21

Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol (2006) 1.21

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ (2003) 1.21

Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731. Mol Biol Cell (2010) 1.20

Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax (2010) 1.20

Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem (2008) 1.20